Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07214415 · ClinicalTrials.gov registry record · Phase 2
Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy
A Phase 2 study of TBI (Traumatic Brain Injury) and PTSD - Post Traumatic Stress Disorder, sponsored by Summit Hyperbarics and Wellness.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 54
- Enrollment target
- 1
- Study location
NCT07214415: Recruiting Phase 2 study of TBI (Traumatic Brain Injury) and PTSD - Post Traumatic Stress Disorder, sponsored by Summit Hyperbarics and Wellness.
NCT07214415 is a Phase 2 study of TBI (Traumatic Brain Injury) and PTSD - Post Traumatic Stress Disorder that is actively recruiting participants, run by Summit Hyperbarics and Wellness. The registered enrollment target is 54 participants, below the 171-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07214415, a Phase 2 study of TBI (Traumatic Brain Injury) and PTSD - Post Traumatic Stress Disorder, is actively recruiting participants, sponsored by Summit Hyperbarics and Wellness.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate how hyperbaric oxygen therapy (HBOT) may affect cognitive functioning, post-traumatic stress disorder (PTSD), depression, anxiety, and overall quality of life in veterans. 1. Does Hyperbaric Oxygen Therapy improve cognitive functioning, psychological well-being, and quality of life among veterans, as measured by pre-and post-treatment scores? 2. To what extent does Hyperbaric Oxygen Therapy improve cognitive functioning, psychological well-being, and qualify of life among veterans, after controlling for demographic characteristics.
Primary Outcome
Self-report questionnaire to assess symptoms of PTSD
Conditions Studied
Interventions
- DRUG Hyperbaric Oxygen Therapy
Study Locations (1)
Idaho
- Summit Hyperbarics and Wellness - Boise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2026-09-15 |
| Phase | Phase 2 |
What NCT07214415 shows while recruiting
NCT07214415 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 171-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (68% lower).
The record links to 3 conditions, with TBI (Traumatic Brain Injury) appearing as the primary indexed condition, and to 1 intervention - of which Hyperbaric Oxygen Therapy is the first listed.
NCT07214415 reports a single indexed study location in Idaho.
Frequently Asked Questions
What is clinical trial NCT07214415 about?
NCT07214415 is a clinical study titled "Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy". The purpose of this study is to evaluate how hyperbaric oxygen therapy (HBOT) may affect cognitive functioning, post-traumatic stress disorder (PTSD), depression, anxiety, and overall quality of life in veterans. 1. Does Hyperbaric Oxygen Therapy improve cognitive functioning, psychological well-be...
What is the current status of trial NCT07214415?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2025-10-01. Estimated completion is 2026-09-15.
What conditions does trial NCT07214415 study?
This clinical trial studies the following conditions: TBI (Traumatic Brain Injury), PTSD - Post Traumatic Stress Disorder, Post Concussive Syndrome.
What interventions are being tested in trial NCT07214415?
The interventions under investigation include: Hyperbaric Oxygen Therapy (DRUG).
Who is sponsoring clinical trial NCT07214415?
This trial is sponsored by Summit Hyperbarics and Wellness, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07214415 being conducted?
This trial has 1 study location across Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for TBI (Traumatic Brain Injury)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07214415's enrollment target sits among peer trials
54 13th of 20 higher than 8 of 20 other TBI (Traumatic Brain Injury) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other TBI (Traumatic Brain Injury) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Growth Hormone Replacement Therapy for Retried Professional Football Players
RECRUITING · Phase 2
-
Autologous Stem Cell Study for Adult TBI (Phase 2b)
ACTIVE NOT RECRUITING · Phase 2
-
Stimulating After Recovery From Traumatic Brain Injury
RECRUITING · Early Phase 1
-
Cognitive Rehabilitation for Refugees With Traumatic Brain Injury and Cognitive Impairment
RECRUITING · NA
-
Depth Electrode Detection of Cortical Spreading Depolarization After Traumatic Brain Injury
RECRUITING · NA
-
Evaluation of Well-being Interventions in Adults With TBI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI